Medical/Pharmaceuticals

Sihuan Pharmaceutical (0460.HK): Establishment of Joint Venture with Bluepha Co., Ltd.

HONG KONG, Jan. 21, 2022 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Co., Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group:" Hong Kong Stock Exchange Stock Code: 0460) is pleased to announce thatBeijing MeiYan KongJian...

2022-01-21 11:12 6677

Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an orally bioavailable Chimeric Degrader targeting Androgen Receptor for Prostate Cancer Treatment

MELBOURNE, Australia, Jan. 21, 2022 /PRNewswire/ -- Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies, announced that the first patient with metastat...

2022-01-21 05:30 2973

Suvoda Exceeds 2021 Targets; Poised for Continued Growth Supporting Complex Clinical Trials in 2022

Surpasses 900 trials across 65 countries, expands leadership team and product offerings, and posts another year of 30% growth, all while maintaining an exceptional performance level. PHILADELPHIA, Jan. 20, 2022 /PRNewswire/ -- Suvoda, LLC, a global clinical trial technology company that speciali...

2022-01-20 23:05 2921

Bridget Johnson Joins CSafe Global as Senior Vice President of Marketing

CSafe Global makes strategic addition to its senior leadership team bringing Bridget Johnson on board as the SVP of Marketing   DAYTON, Ohio, Jan. 20, 2022 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharma...

2022-01-20 21:15 6599

Victor Papamoniodis Joins Medison Pharma as VP International Markets

ZUG, Switzerland, Jan. 20, 2022 /PRNewswire/ -- Medison , a global pharma company focused on providing access to highly innovative therapies to patients in international markets ("Medison"), is proud to announce the joining ofVictor Papamoniodis in the newly create...

2022-01-20 20:35 3486

Sputnik V demonstrates strong protection against Omicron variant, with over 2 times higher virus neutralizing activity compared to the Pfizer vaccine according to a unique independent comparative study conducted by the Spallanzani Institute in Italy

Previous studies also demonstrated additional significant strengthening of protection against Omicron by Sputnik Light booster, which can also be a universal booster to other vaccines to strengthen and lengthen their protection against Omicron. MOSCOW, Jan. 20, 2022 /PRNewswire/ -- * A uniqu...

2022-01-20 19:00 5675

Successful Completion of First Patient Implantation of MINI WELL® and MINI WELL TORIC® Extended Depth-of-Focus IOLs in China Announced by Affamed Technologies, Joint Venture between AffaMed Therapeutics and SIFI

CATANIA, Italy, Jan. 20, 2022 /PRNewswire/ -- SIFI, a leading international ophthalmic company headquartered inItaly, is pleased to divulge the successful completion of the first patient implantation of MINI WELL® and MINI WELL TORIC® IOLs inChina, announced via Affamed Technologies, Joint Ventur...

2022-01-20 16:00 3923

Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into Exclusive Licensing Agreement for commercializing Ryaltris (TM) Nasal Spray in Singapore, Hong Kong and Vietnam

* Under the terms of the agreement, Glenmark will be responsible for the manufacture and supply of Ryaltris™, while Lotus International Pte. Ltd. will be responsible for the commercialization of Ryaltris™ (subject to receipt of regulatory approvals) across these markets. * Glenmark will recei...

2022-01-20 15:48 3519

Wonju Medical Industry Techno Valley Supports Overseas Market Entry of Medical Devices Through Participation of Dubai Arab Health 2022

SEOUL, South Korea, Jan. 20, 2022 /PRNewswire/ -- Wonju Medical Industry Techno Valley (PresidentKim Kwang-soo/hereafter WMIT), the largest exhibition in the Middle East, will be held at the Dubai World Trade Center for a total of 4 days fromJanuary 24 to 27 next year, "Arab Health 2022" to form ...

2022-01-20 13:00 2682

Award: Boehringer Ingelheim is Global Top Employer 2022

* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the third consecutive year for the certification inVietnam * High scores in values, ethics and integrity serve as a driver for a strong cor...

2022-01-20 08:00 6560

Award: Boehringer Ingelheim is Global Top Employer 2022

* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the fourth consecutive year for the certification inThailand * High scores in values, ethics and integrity serve as a driver for a strong c...

2022-01-20 08:00 3284

Award: Boehringer Ingelheim is Global Top Employer 2022

* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the third consecutive year for the certification inIndonesia * High scores in values, ethics and integrity serve as a driver for a strong c...

2022-01-20 08:00 3624

Award: Boehringer Ingelheim is Global Top Employer 2022

* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the fourth consecutive year for the certification inPhilippines * High scores in values, ethics and integrity serve as a driver for a strong...

2022-01-20 08:00 3003

Award: Boehringer Ingelheim is Global Top Employer 2022

* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the second consecutive year for the certification inAustralia & New Zealand * High scores in values, ethics and integrity serve as a driver ...

2022-01-20 08:00 2914

Award: Boehringer Ingelheim is Global Top Employer 2022

* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the fourth consecutive year for the certification inMalaysia * High scores in values, ethics and integrity serve as a driver for a strong c...

2022-01-20 08:00 2951

Award: Boehringer Ingelheim is Global Top Employer 2022

* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the fifth consecutive year for the certification inSingapore * High scores in values, ethics and integrity serve as a driver for a strong c...

2022-01-20 08:00 2641

"JEWISH NOBEL" AWARDED TO PFIZER CEO ALBERT BOURLA

Genesis Prize Chairman highlights immense role of Jewish scientists and doctors in combatting the pandemic: "A very proud moment for the entire Jewish community" JERUSALEM, Jan. 20, 2022 /PRNewswire/ -- Today, The Genesis Prize Foundation announced Dr.Albert Bourla, Chairman and CEO of Pfizer,...

2022-01-20 06:13 2596

Operation Smile Announces 10-Year Commitment to Transform the Lives of 1 Million Patients Globally

VIRGINIA BEACH, Va., Jan. 19, 2022 /PRNewswire/ -- Global nonprofit Operation Smile announced a 10-year commitment today to increase access to care for 1 million patients who need cleft care and other essential surgeries. Entering its 40th anniversary year, the organization will scale up its inve...

2022-01-19 21:36 2161

Seegene to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized for Mass Testing

SEOUL, South Korea, Jan. 19, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, announced today the upcoming launch of the Allplex™ SARS-CoV-2 Fast PCR Assay, which can deliver PCR results in just 60 minutes. The company says that this assay is exp...

2022-01-19 20:00 2733

Octapharma puts a spotlight on the challenges of managing inhibitors in haemophilia A at the 15th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

LACHEN, Switzerland, Jan. 19, 2022 /PRNewswire/ -- The virtual symposium held on Wednesday, February 2, 2022, at 18:00 CET, will tell the story of the Rodriguez family and their two sons with haemophilia A as they navigate the challenges of inhibitor management. The development of inhibitors to r...

2022-01-19 19:00 2672
1 ... 347348349350351352353 ... 382